Cohorts included patients who were on standard budesonide and formoterol therapy and patients who were on this standard therapy as well as a GLP-1 receptor agonist, which included semaglutide, tirzepatide, exenatide, dulaglutide or liraglutide, with 1,066 patients in each group
Gut Microbes in Polycystic Ovary Syndrome and Associated Comorbidities
206 Combined administration of shikonin and cisplatin increases Fe 2+ , ROS, and lipid peroxidation (LPO) levels and downregulates GPX4 in ovarian cancer cells, reducing cisplatin resistance by inducing ferroptosis
What is Lavender Sky Health
Mol Autism 7:26 Mai J, Sorensen PS, Hansen JC (1990) High dose antioxidant supplementation to MS patients